BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

258 hedge funds and large institutions have $1.26B invested in BioCryst Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 79 increasing their positions, 90 reducing their positions, and 32 closing their positions.

Holders
258
Holders Change
+2
Holders Change %
+0.78%
% of All Funds
3.44%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
35
Increased
79
Reduced
90
Closed
32
Calls
$12.1M
Puts
$8.5M
Net Calls
+$3.61M
Net Calls Change
-$2.58M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$165M
2
EP
2
Eversept Partners
New York
$14.9M
3
BlackRock
3
BlackRock
New York
$166M
4
HIM
4
Hillsdale Investment Management
Ontario, Canada
$4.08M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$3.98M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$954K
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$25.7M
3
State Street
3
State Street
Massachusetts
$56.4M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.85M
5
Goldman Sachs
5
Goldman Sachs
New York
$9.71M
Name Market Value Shares Shares
Change 		Shares
Change %
Deutsche Bank
51
Deutsche Bank
Germany
$3.9M 519,217 +58,687 +13%
TI
52
Trexquant Investment
Connecticut
$3.72M 494,356 -386,635 -44%
JPMorgan Chase & Co
53
JPMorgan Chase & Co
New York
$3.57M 474,376 -102,753 -18%
Barclays
54
Barclays
United Kingdom
$3.49M 464,246 -12,426 -3%
WP
55
Woodline Partners
California
$3.39M 450,199 +450,199 New
DMKJ
56
David M. Knott Jr
$3.31M 440,000 +58,000 +15%
State of Wisconsin Investment Board
57
State of Wisconsin Investment Board
Wisconsin
$3.21M 427,282 +243,354 +132%
Arrowstreet Capital
58
Arrowstreet Capital
Massachusetts
$3.03M 403,412 -27,818 -6%
UBS AM
59
UBS AM
Illinois
$3.02M 401,111 +11,581 +3%
Swiss National Bank
60
Swiss National Bank
Switzerland
$2.91M 386,568 +22,600 +6%
Squarepoint
61
Squarepoint
New York
$2.71M 359,881 +345,729 +2,443%
Walleye Capital
62
Walleye Capital
New York
$2.7M 359,522 +100,140 +39%
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
$2.37M 315,263 +86,173 +38%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$2.32M 309,132 +5,615 +2%
Citigroup
65
Citigroup
New York
$2.08M 276,702 +123,779 +81%
AllianceBernstein
66
AllianceBernstein
Tennessee
$2.07M 275,390 -400 -0.1%
Legal & General Group
67
Legal & General Group
United Kingdom
$2.07M 275,083 +25,338 +10%
Qube Research & Technologies (QRT)
68
Qube Research & Technologies (QRT)
United Kingdom
$2.05M 272,844 +18,943 +7%
JF
69
Jump Financial
Illinois
$1.98M 263,338 -8,401 -3%
Franklin Resources
70
Franklin Resources
California
$1.97M 262,382 -1,366 -0.5%
Citadel Advisors
71
Citadel Advisors
Florida
$1.94M 258,545 -20,598 -7%
Jacobs Levy Equity Management
72
Jacobs Levy Equity Management
New Jersey
$1.86M 247,795 -119,719 -33%
UBS Group
73
UBS Group
Switzerland
$1.81M 240,352 -184,667 -43%
Rafferty Asset Management
74
Rafferty Asset Management
New York
$1.77M 234,836 -136,198 -37%
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
$1.7M 225,700 -9,166 -4%
1 2
3
4 5